Hospital General Universitario de Valencia
Valencia, Spain
NCT Number: NCT04743154
Patients with STEMI and multivessel disease in whom the culprit lesion has been successfully revascularized during prmimary PCI, will be randomized to in-hospital or after-discharge complete revascularization.
The purpose of this study is to evaluate the impact of these two different strategies in terms of hospital stay.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Valencia, Spain
STEMI patients with mutivessel disease are, after successful primary angioplasty, randomized 1:1 ratio to either in-hospital complete revascularization or after-discharge complete revascularization strategy.
Eligible non-culprit coronary arteries must be >2.0 mm in diameter and at the discretion of the operator suitable for PCI. Only arteries with angiographically stenoses ≥70% or between ≥50% and <70 in proximal segments can be randomized.
Patients in the in-hospital revascularization group will undergo to non-culprit percutaneous coronary intervention (PCI) at least 24 hours after ST-segment elevation myocardial infarction. On the other hand, patients in the after-discharge group will undergo to non-culprit PCI within 4-6 weeks after STEMI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure during index admission.
To perform percutaneous coronary intervention of non-culprit vessels in a staged procedure after hospital discharge.
Time frame: 6 months
To evaluate the impact of two different revascularization strategies (in-hospital versus after-discharge) in terms of hospital stay (days) in patients with a STEMI and multivessel disease.
Time frame: 1 year
Composite of cardiovascular death, myocardial infarction, or ischemia driven revascularization of non-culprit coronary lesions eligible for and randomized to either of the two strategies.
Time frame: 6 months
Evaluate the presence of ischemia by analyzing the fractional flow reserve of angiographically moderate stenoses (≥50% and <70) in proximal segments of the anterior descending, circumflex, or right coronary artery.
Hospital General Universitario de Valencia
Other
In-hospital Versus After-discharge Complete Revascularization in STEMI Patients With Multivessel Disease.
Acronym: REVIVA-ST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07598565
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Roma, RM, Italy
View Trial DetailsNCT04014972
Acute Aortic Syndrome, Aneurysm
View Trial DetailsNCT06945900
Cardiovascular Diseases, Heart Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03070496
Cardiovascular Diseases, Heart Diseases
Bron, France
View Trial Details